APPLICATION
ANDA075640
TYPE
ANDA
ORIGINAL APPROVAL
2000-01-28
LATEST ACTION
2022-06-06
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
HYDROCHLOROTHIAZIDEDiscontinued
HYDROCHLOROTHIAZIDE 12.5MG · CAPSULE · ORAL
Approval history
2022-06-06Labeling · Supplement 23 · standardAP
2012-08-29Labeling · Supplement 15 · standardAP
2002-05-10Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.